Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds

13G Filing: Biotechnology Value Fund LP and Contrafect Corp (CFRX)

Published on July 31, 2017 at 1:00 pm by Insider Monkey Staff in Hedge Funds
<< Prev
Page 10 of 13
Next >>
See All

Page 10 of 13 – SEC Filing

Item 2(d). Title of Class of Securities:

Common Stock, par value $0.0001 per share (the “Common
Stock”)

Item 2(e). CUSIP Number:

212326102

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person
Filing is a:
/x/ Not applicable.
(a) / / Broker or dealer registered under Section 15 of the Exchange Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act.
(d) / / Investment company registered under Section 8 of the Investment Company Act.
(e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
(k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
Item 4. Ownership
(a) Amount beneficially owned:

The Reporting Persons hold 3,500,000
warrants, exercisable for an aggregate of 1,750,000 shares of Common Stock (the “Warrants”). Each Warrant is exercisable
for ½ share of Common Stock. The Warrants are only exercisable to the extent that the holder, together with its affiliates
and any other person or entity acting as a group, would not beneficially own more than 9.99% of the outstanding Common Stock after
giving effect to such exercise, as such percentage ownership is determined in accordance with the terms of the Warrant (the “Beneficial
Ownership Limitation”), except that upon at least 61 days prior notice from the holder to the Issuer, the holder may waive
the Beneficial Ownership Limitation. The Beneficial Ownership Limitation does not limit the Reporting Persons at this time, as
none of the Reporting Persons may be deemed to beneficially own more than 9.99% after giving effect to the exercise of the Warrants.

10

Follow Contrafect Corp (NASDAQ:CFRX)
<< Prev
Page 10 of 13
Next >>
See All

Related Insider Monkey Articles
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS...13G Filing: Tontine Asset Associates, L.L.C. and Skyline Corporation (SKY)
13G Filing: Senator Investment Group and Hyatt Hotels Corporation (H)13G Filing: DG Capital Management and Ricebran Technologies (RIBT)
13G Filing: Saba Capital and First Trust High Income Longort Fund (FSD)13G Filing: Biotechnology Value Fund LP and Alpine Immune Sciences Inc. (ALPN...